Isolation and identification of bioactive compounds from Antrodia camphorata against ESKAPE pathogens.
PLoS One
; 18(10): e0293361, 2023.
Article
em En
| MEDLINE
| ID: mdl-37889913
ABSTRACT
Antimicrobial resistance is a major threat to human health globally. Antrodia camphorata was grown in a malt/yeast extract broth liquid medium for 15 days. Then, 4-L fermentation broth was harvested, yielding 7.13 g of the ethyl acetate extract. By tracing the antimicrobial activity, 12.22 mg of the antimicrobial compound was isolated. The structure of 5-methyl-benzo [1,3]-dioxole-4,7-diol (MBBD) was elucidated using NMR and MS data analyses. The antibacterial activity of MBBD was detected through the microbroth dilution method. MBBD exhibited broad-spectrum antibacterial activity. The minimum inhibitory concentration (MIC) range of MBBD for drug-resistant pathogenic bacteria was 64-256 µg/mL, with the lowest MIC observed for Acinetobacter baumannii (64 µg/mL), followed by Pseudomonas aeruginosa (MIC = 128 µg/mL). Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus faecalis, and Escherichia coli were also sensitive, with an MIC of 256 µg/mL. The MIC range of MBBD against 10 foodborne pathogens was 12.5-100 µg/mL. Based on the results of this study, MBBD exhibits broad-spectrum antibacterial activity, particularly demonstrating excellent inhibitory effects against A. baumannii. MBBD will be good candidates for new antimicrobial drugs.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Polyporales
/
Anti-Infecciosos
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article